Advanced search
Publication Cover
mAbs Volume 14, 2022 - Issue 1
Submit an article Journal homepage
4,468
Views
4
CrossRef citations to date
0
Altmetric
Report article

A strategy for the efficient construction of anti-PD1-based bispecific antibodies with desired IgG-like properties

Jie ZhaoResearch and development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. A 3SBio Inc. Company, Shanghai, ChinaView further author information
,
Liangfeng JiangResearch and development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. A 3SBio Inc. Company, Shanghai, ChinaView further author information
,
Haodong YangResearch and development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. A 3SBio Inc. Company, Shanghai, ChinaView further author information
,
Lan DengResearch and development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. A 3SBio Inc. Company, Shanghai, ChinaView further author information
,
Xiaoqing MengResearch and development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. A 3SBio Inc. Company, Shanghai, ChinaView further author information
,
Jian DingResearch and development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. A 3SBio Inc. Company, Shanghai, ChinaView further author information
,
Sixing YangResearch and development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. A 3SBio Inc. Company, Shanghai, ChinaView further author information
,
Le ZhaoResearch and development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. A 3SBio Inc. Company, Shanghai, ChinaView further author information
,
Wei XuResearch and development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. A 3SBio Inc. Company, Shanghai, ChinaView further author information
,
Xiaolong WangResearch and development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. A 3SBio Inc. Company, Shanghai, ChinaView further author information
,
Zhenping ZhuResearch and development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. A 3SBio Inc. Company, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Haomin HuangResearch and development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. A 3SBio Inc. Company, Shanghai, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2044435 | Received 13 Sep 2021, Accepted 15 Feb 2022, Published online: 03 Mar 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.